Literature DB >> 23591766

Enhanced expression of activation-induced cytidine deaminase in human gastric mucosa infected by Helicobacter pylori and its decrease following eradication.

Naoyoshi Nagata1, Junichi Akiyama, Hiroyuki Marusawa, Takuro Shimbo, Yi Liu, Toru Igari, Ryo Nakashima, Hidenobu Watanabe, Naomi Uemura, Tsutomu Chiba.   

Abstract

BACKGROUND: Recent studies have shown important roles for activation-induced cytidine deaminase (AID), an intrinsic genome mutator, in H. pylori-associated gastric cancer development. Here, we evaluated the relationship between H. pylori-induced gastritis and AID expression from human biopsy specimens.
METHODS: In 109 patients with dyspeptic symptoms who had undergone endoscopy and received biopsy of the antrum, angulus, and corpus, H. pylori infection was diagnosed by serologic test, (13)C urea breath test, and histological examination. Histological scores of H. pylori, neutrophils, mononuclear cells, atrophy, and intestinal metaplasia (IM) were assessed using the updated Sydney system (USS). Immunohistochemical AID expression of the biopsy specimens was scored.
RESULTS: Sixty of 109 (55.0 %) patients were positive for H. pylori and eradication was successful in 48 patients. AID expression in H. pylori-infected mucosa was significantly higher (p < 0.01) than in non-infected mucosa. AID expression was highest in the antrum and was significantly (p < 0.01) reduced toward the proximal portion of the stomach. For USS, multivariate analysis using linear regression revealed that mononuclear cell infiltration (p < 0.01) and IM (p < 0.05) correlated independently with AID expression. After eradication of H. pylori, AID expression was significantly decreased (p < 0.01), but was still higher than that in H. pylori-negative patients in all sites of the stomach.
CONCLUSIONS: AID expression is elevated in H. pylori-positive patients and is reduced following H. pylori eradication. Moreover, AID expression is highest in the antrum and correlated with severity of chronic inflammation and IM, suggesting an important role for AID in gastric cancer development through gastritis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23591766     DOI: 10.1007/s00535-013-0808-z

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  36 in total

Review 1.  The kappa statistic in reliability studies: use, interpretation, and sample size requirements.

Authors:  Julius Sim; Chris C Wright
Journal:  Phys Ther       Date:  2005-03

2.  Staging gastritis: an international proposal.

Authors:  Massimo Rugge; Robert M Genta
Journal:  Gastroenterology       Date:  2005-11       Impact factor: 22.682

Review 3.  DNA methylation as a marker for the past and future.

Authors:  Toshikazu Ushijima; Takeshi Nakajima; Takao Maekita
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

4.  Expression of AID, P53, and Mlh1 proteins in endoscopically resected differentiated-type early gastric cancer.

Authors:  Yohei Takeda; Kazuo Yashima; Akihiro Hayashi; Shuji Sasaki; Koichiro Kawaguchi; Kenichi Harada; Yoshikazu Murawaki; Hisao Ito
Journal:  World J Gastrointest Oncol       Date:  2012-06-15

5.  The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis.

Authors:  Lisette G Capelle; Annemarie C de Vries; Jelle Haringsma; Frank Ter Borg; Richard A de Vries; Marco J Bruno; Herman van Dekken; Jos Meijer; Nicole C T van Grieken; Ernst J Kuipers
Journal:  Gastrointest Endosc       Date:  2010-04-09       Impact factor: 9.427

6.  Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients.

Authors:  G M Naylor; T Gotoda; M Dixon; T Shimoda; L Gatta; R Owen; D Tompkins; A Axon
Journal:  Gut       Date:  2006-04-07       Impact factor: 23.059

7.  Up-regulation of activation-induced cytidine deaminase causes genetic aberrations at the CDKN2b-CDKN2a in gastric cancer.

Authors:  Yuko Matsumoto; Hiroyuki Marusawa; Kazuo Kinoshita; Yoko Niwa; Yoshiharu Sakai; Tsutomu Chiba
Journal:  Gastroenterology       Date:  2010-07-14       Impact factor: 22.682

Review 8.  Helicobacter pylori and gastric carcinogenesis.

Authors:  Masanori Hatakeyama
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

9.  Regulation of IL-18 in Helicobacter pylori infection.

Authors:  Kazuyoshi Yamauchi; Il-Ju Choi; Hong Lu; Hiroaki Ogiwara; David Y Graham; Yoshio Yamaoka
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

Review 10.  Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation.

Authors:  Tsutomu Chiba; Hiroyuki Marusawa; Toshikazu Ushijima
Journal:  Gastroenterology       Date:  2012-07-13       Impact factor: 22.682

View more
  8 in total

1.  Therapy with omeprazole modulates regulatory T cell/T helper 17 immune response in children with duodenal ulcers.

Authors:  Chuan-Ying Li; Cheng Wu
Journal:  Inflammopharmacology       Date:  2017-07-22       Impact factor: 4.473

2.  AID, p53 and MLH1 expression in early gastric neoplasms and the correlation with the background mucosa.

Authors:  Soichiro Kawata; Kazuo Yashima; Sohei Yamamoto; Shuji Sasaki; Yohei Takeda; Akihiro Hayashi; Kazuya Matsumoto; Koichiro Kawaguchi; Kenichi Harada; Yoshikazu Murawaki
Journal:  Oncol Lett       Date:  2015-06-09       Impact factor: 2.967

3.  Comparison of the Clinicopathological Characteristics and Genetic Alterations Between Patients with Gastric Cancer with or Without Helicobacter pylori Infection.

Authors:  Wen-Liang Fang; Kuo-Hung Huang; Shih-Ching Chang; Chien-Hsing Lin; Ming-Huang Chen; Yee Chao; Su-Shun Lo; Anna Fen-Yau Li; Chew-Wun Wu; Yi-Ming Shyr
Journal:  Oncologist       Date:  2019-02-22

Review 4.  Modulation of p53 during bacterial infections.

Authors:  Christine Siegl; Thomas Rudel
Journal:  Nat Rev Microbiol       Date:  2015-11-09       Impact factor: 60.633

Review 5.  Gastric Carcinogenesis and Underlying Molecular Mechanisms: Helicobacter pylori and Novel Targeted Therapy.

Authors:  Toshihiro Nishizawa; Hidekazu Suzuki
Journal:  Biomed Res Int       Date:  2015-04-07       Impact factor: 3.411

Review 6.  Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways.

Authors:  Xin Yong; Bo Tang; Bo-Sheng Li; Rui Xie; Chang-Jiang Hu; Gang Luo; Yong Qin; Hui Dong; Shi-Ming Yang
Journal:  Cell Commun Signal       Date:  2015-07-11       Impact factor: 5.712

Review 7.  Genetic Pathogenesis of Inflammation-Associated Cancers in Digestive Organs.

Authors:  Risa Nakanishi; Takahiro Shimizu; Ken Kumagai; Atsushi Takai; Hiroyuki Marusawa
Journal:  Pathogens       Date:  2021-04-09

8.  Identification and Verification of Potential Biomarkers in Gastric Cancer By Integrated Bioinformatic Analysis.

Authors:  Chenyu Sun; Yue Chen; Na Hyun Kim; Scott Lowe; Shaodi Ma; Zhen Zhou; Rachel Bentley; Yi-Sheng Chen; Margarita Whitaker Tuason; Wenchao Gu; Chandur Bhan; John Pocholo Whitaker Tuason; Pratikshya Thapa; Ce Cheng; Qin Zhou; Yanzhe Zhu
Journal:  Front Genet       Date:  2022-07-15       Impact factor: 4.772

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.